돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 415785생성일: 2026년 10월 24일

Iodine → 5-Bromo-4-methyl-3-nitropyridine-2-carboxaldehyde

https://huagongshe.com/ko/reaction/415785

반응식

참여 물질

역할이름HCID투입량
반응물IodineHCID 807—
반응물WaterHCID 962—
반응물2-Amino-5-bromo-4-methyl-3-nitropyridineHCID 7213207—
반응물Sodium periodateHCID 23667635—
반응물5-Bromo-2-iodo-4-methyl-3-nitropyridineHCID 86625594—
촉매Copper bromide (CuBr2)HCID 24611—
촉매Osmium TetroxideHCID 30318—
용매TetrahydrofuranHCID 8028—
생성물5-Bromo-4-methyl-3-nitro-2-vinylpyridineHCID 66620963—
생성물5-Bromo-4-methyl-3-nitropyridine-2-carboxaldehydeHCID 8662559359%

반응 단계

2-Amino-3-(6-bromo-3-methoxy-7-methyl-2H-pyrazolo[4,3-b]pyridin-2-yl)-2-methylpropionitrile (20 mg) was prepared using a procedure similar to that described in Example 1, part b, except starting from 1-(6-bromo-3-methoxy-7-methyl-2H-pyrazolo[4,3-b]pyridin-2-yl)propan-2-one (117 mg). 1-(6-Bromo-3-methoxy-7-methyl-2H-pyrazolo[4,3-b]pyridin-2-yl)propan-2-one was prepared using a procedure similar to that described in Example 105 part a to d except using 5-bromo-4-methyl-3-nitropyridine-2-carboxaldehyde (5.5 g) in part a to yield [2-(tert-butyldimethylsilanyloxy)propyl]-(5-bromo-4-methyl-3-nitropyridin-2-yl-methyl)amine (6 g, 67%). 5-Bromo-4-methyl-3-nitro-pyridine-2-carboxaldehyde was prepared using a procedure similar to that described in Example 136 part a to c except starting from 2-amino-5-bromo-4-methyl-3-nitropyridine (58.6 g) and using iodine (64 g) in part a instead of copper bromide to generate 5-bromo-2-iodo-4-methyl-3-nitropyridine (28.7 g, 33%). Oxidative cleavage using a 4% solution of osmium tetroxide in water (3 mL) and sodium periodate (23.1 g) was carried out in a mixture of THF and water (10:1, 330 mL) in part c instead of ozonolysis following a procedure similar to that described in Example 61 to afford 5-bromo-4-methyl-3-nitropyridine-2-carboxaldehyde (11.7 g, 59%) from 5-bromo-4-methyl-3-nitro-2-vinylpyridine (18.8 g). 2-Amino-5-bromo-4-methyl-3-nitropyridine (120.2 g, 85%) was prepared using a procedure similar to that described in Example 38 part a except starting from 2-amino-4-methyl-3-nitropyridine (101.5 g).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08088801B2
출처 데이터셋uspto-grants-2012_01
ORD IDord-b8407200b61f4402a6693089e5c44e76
출처 메모uspto-grants-2012_01